PPARA and metabolic dysfunction-associated steatotic liver disease: Along with the studies showing that hyperactivation of PPAR-α causes NASH (Fan et al. 1998; Huang et al. 2011; Meyer et al. 2003), this finding illustrates the dual role that PPAR-α activity may have as either a protective or promoting factor in progressive NAFLD depending on the context.